C Kluft

1.6k total citations
26 papers, 1.0k citations indexed

About

C Kluft is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, C Kluft has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in C Kluft's work include Adipokines, Inflammation, and Metabolic Diseases (11 papers), Lipoproteins and Cardiovascular Health (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). C Kluft is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (11 papers), Lipoproteins and Cardiovascular Health (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). C Kluft collaborates with scholars based in Netherlands, United Kingdom and Israel. C Kluft's co-authors include Aafje Sierksma, Evert G. Schouten, A. Edo Meinders, Menno V. Huisman, Marcel A. van de Ree, P. Hans, Tiny Hoekstra, Johanna M. Geleijnse, J.A. Gevers Leuven and Hanno Pijl and has published in prestigious journals such as The Lancet, Cardiovascular Research and Atherosclerosis.

In The Last Decade

C Kluft

26 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Kluft Netherlands 14 295 257 225 210 169 26 1.0k
Beate Tiran Austria 20 239 0.8× 306 1.2× 206 0.9× 156 0.7× 78 0.5× 67 1.3k
Adriana Branchi Italy 14 320 1.1× 173 0.7× 296 1.3× 361 1.7× 59 0.3× 40 1000
Francesco Scopacasa Italy 19 340 1.2× 436 1.7× 451 2.0× 184 0.9× 60 0.4× 29 1.3k
Natale Vazzana Italy 19 263 0.9× 549 2.1× 218 1.0× 346 1.6× 72 0.4× 31 1.5k
David Mymin Canada 17 335 1.1× 329 1.3× 510 2.3× 272 1.3× 91 0.5× 41 1.4k
Yung‐Hsiung Lai Taiwan 19 158 0.5× 109 0.4× 112 0.5× 179 0.9× 145 0.9× 43 1.2k
Kousuke Negishi Japan 20 278 0.9× 210 0.8× 271 1.2× 105 0.5× 146 0.9× 27 1.7k
M.A. Barradas United Kingdom 23 126 0.4× 460 1.8× 395 1.8× 186 0.9× 178 1.1× 72 1.7k
Elisabet Vilella Spain 18 160 0.5× 316 1.2× 492 2.2× 448 2.1× 42 0.2× 35 1.4k
C. Wanner Germany 17 72 0.2× 160 0.6× 263 1.2× 209 1.0× 177 1.0× 31 1.3k

Countries citing papers authored by C Kluft

Since Specialization
Citations

This map shows the geographic impact of C Kluft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Kluft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Kluft more than expected).

Fields of papers citing papers by C Kluft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Kluft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Kluft. The network helps show where C Kluft may publish in the future.

Co-authorship network of co-authors of C Kluft

This figure shows the co-authorship network connecting the top 25 collaborators of C Kluft. A scholar is included among the top collaborators of C Kluft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Kluft. C Kluft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kluft, C, et al.. (2014). Consequences for the APTT due to direct action of factor XIa on factor X, resulting in bypassing factors VIII-IX. Thrombosis Research. 135(1). 198–204. 3 indexed citations
2.
Meijer, Piet, Fred J.L.M. Haas, & C Kluft. (2007). QUANTIFICATION OF THE MEASUREMENT UNCERTAINTY FOR D-DIMER ASSAY RESULTS AROUND THE CUT-OFF LEVEL: IMPROVED DECISION RULES REQUIRED?. Journal of Thrombosis and Haemostasis. 5. P–T. 1 indexed citations
3.
Ceconi, Claudio, K. Fox, W. Remme, et al.. (2006). ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovascular Research. 73(1). 237–246. 135 indexed citations
4.
Hoekstra, Tiny, Evert G. Schouten, C Kluft, & Johanna M. Geleijnse. (2004). Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thrombosis and Haemostasis. 91(5). 861–872. 94 indexed citations
5.
Kluft, C. (2004). Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers. European Heart Journal Supplements. 6. C21–C27. 10 indexed citations
6.
Geelen, Anouk, Ingeborg A. Brouwer, Evert G. Schouten, et al.. (2004). Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. European Journal of Clinical Nutrition. 58(10). 1440–1442. 78 indexed citations
7.
Witte, Daniel R., Wendy M.R. Broekmans, A.F.M. Kardinaal, et al.. (2003). Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis. 170(1). 147–153. 38 indexed citations
8.
Ree, Marcel A. van de, et al.. (2002). Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis. 166(1). 129–135. 131 indexed citations
9.
Sierksma, Aafje, et al.. (2002). Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. European Journal of Clinical Nutrition. 56(11). 1130–1136. 179 indexed citations
10.
Kluft, C, J.A. Gevers Leuven, FM Helmerhorst, & H. M. J. Krans. (2002). Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascular Pharmacology. 39(3). 149–154. 60 indexed citations
11.
Kluft, C. (2002). HRT effects on inflammatory markers: is chronic inflammation a contra-indication for HRT?. International Congress Series. 1229. 103–108. 4 indexed citations
12.
Riese, Harriëtte, Tanja G. M. Vrijkotte, Piet Meijer, C Kluft, & Eco J. C. de Geus. (2002). Diagnostic strategies for C-reactive protein. BMC Cardiovascular Disorders. 2(1). 12 indexed citations
13.
Kluft, C. (2002). How best to counteract the enemies? By controlling inflammation in the coronary circulation. European Heart Journal Supplements. 4. G53–G65. 3 indexed citations
14.
Pijl, Hanno, et al.. (2000). Consumption of black and green tea has no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. European Journal of Clinical Nutrition. 54(10). 757–763. 80 indexed citations
15.
Kluft, C. (1999). Pro-inflammatory effect of oestrogens. Fibrinolysis & proteolysis. 13(6). 217–219. 4 indexed citations
16.
Kluft, C, et al.. (1999). Statins and C-reactive protein. The Lancet. 353(9160). 1274–1274. 35 indexed citations
17.
Slagboom, P. Eline & C Kluft. (1996). Genetic studies of complex diseases: giant steps from promise to proof. Fibrinolysis and Proteolysis. 10. 1–2. 1 indexed citations
18.
Kluft, C, et al.. (1989). Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.. PubMed. 113(4). 493–7. 40 indexed citations
19.
Belch, J. J. F., Ricky Madhok, B. McArdle, et al.. (1986). The Effect of Increasing Fibrinolysis in Patients with Rheumatoid Arthritis: A Double Blind Study of Stanozolol. QJM. 58(225). 19–27. 27 indexed citations
20.
Kluft, C, P. Cooper, A.F.H. Jie, et al.. (1985). Evaluation of Euglobulin Methods for the Study of Blood Fibrinolytic Activity: Results for Patients with Rheumatoid Arthritis and in the Postoperative Period. Pathophysiology of Haemostasis and Thrombosis. 15(2). 144–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026